Literature DB >> 28304560

Studies on Synergism in Combinations of Anti-Tumour Agents in Chick Embryos.

B A Diwan1, B K Batra1.   

Abstract

Experiments have been carried out in which the effects of hydroxyurea alone and 5-BUdR alone, as well as in combination, on the development of chicken embryos were studied. The results were as follows: 1. Pilot experiments showed that neither hydroxyurea (0.05 mg/egg) or BUdR (0.025 mg/ egg) alone produced abnormalities during development. 2. When hydroxyurea was administered at 24 hours incubation and 5-BUdR 6 hours later, mortality was high. Mortality decreased as the interval between the two treatments was lengthened to 12 hours and 24 hours. 3. The incidence of beak abnormalities and micromelia rose when hydroxyurea treatment was followed by 5-BUdR by 6 hours or 12 hours. The incidence and severity of the defects declined as the interval was increased to 24 hours. 4. Whether 5-BUdR was injected first followed by hydroxyurea or hydroxyurea was followed by 5-BUdR, when the interval between the initial and the second injection was 6 or 12 hours, the toxic effects and the typical symptoms observed in the embryos were similar. 5. When the time interval between the injection of 5-BUdR followed by hydroxyurea was 24 hours, the mortality as well as incidence of typical abnormalities were reduced considerably. 6. It is supposed that the absence of any remarkable morphological defects when embryos were treated either with hydroxyurea or BUdR alone might be due to a repair mechanism in the DNA of the cells. The pronounced synergistic effects of combination of hydroxyurea and 5-BUdR reported here, could be due to the blockade of thede-novo biosynthesis of DNA.

Entities:  

Year:  1971        PMID: 28304560     DOI: 10.1007/BF00580169

Source DB:  PubMed          Journal:  Wilhelm Roux Arch Entwickl Mech Org        ISSN: 0043-5546


  19 in total

1.  PRELIMINARY SURVEY OF HYDROXYUREA (NSC-32065) AS A TERATOGEN.

Authors:  M L MURPHY; S CHAUBE
Journal:  Cancer Chemother Rep       Date:  1964-08

2.  EVIDENCE FOR THE ACTION OF ALKYLATING AGENTS ON DEOXYRIBONUCLEIC ACID.

Authors:  P BROOKES; P D LAWLEY
Journal:  Exp Cell Res       Date:  1963       Impact factor: 3.905

3.  Experimental and therapeutic modification of mitosis.

Authors:  J J BIESELE
Journal:  Cancer Res       Date:  1962-08       Impact factor: 12.701

4.  Genetics of human cell lines. I. 8-Azaguanine resistance, a selective "single-step" marker.

Authors:  W SZYBALSKI; M J SMITH
Journal:  Proc Soc Exp Biol Med       Date:  1959 Aug-Sep

5.  Mode of action of 5-bromodeoxyuridine on mammalian cells in culture.

Authors:  M T HAKALA
Journal:  J Biol Chem       Date:  1959-12       Impact factor: 5.157

6.  EFFECTS OF FLUORODEOXYURIDINE ON DNA REPLICATION, CHROMOSOME BREAKAGE, AND REUNION.

Authors:  J H Taylor; W F Haut; J Tung
Journal:  Proc Natl Acad Sci U S A       Date:  1962-02       Impact factor: 11.205

7.  Repair of potentially lethal damage in x-irradiated HeLa cells.

Authors:  R A Phillips; L J Tolmach
Journal:  Radiat Res       Date:  1966-11       Impact factor: 2.841

8.  The combined effect of hydroxyurea and x-rays on Chinese hamster cells in vitro.

Authors:  W K Sinclair
Journal:  Cancer Res       Date:  1968-02       Impact factor: 12.701

9.  Hydroxyurea (NSC-32065) in biologic fluids: dose-concentration relationship.

Authors:  G L Beckloff; H J Lerner; D Frost; F M Russo-Alesi; S Gitomer
Journal:  Cancer Chemother Rep       Date:  1965-10

10.  HYDROXYUREA: INHIBITORY EFFECT ON DNA METABOLISM.

Authors:  C W YOUNG; S HODAS
Journal:  Science       Date:  1964-11-27       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.